- Home
- Publications
- Publication Search
- Publication Details
Title
AR-Signaling in Human Malignancies: Prostate Cancer and Beyond
Authors
Keywords
-
Journal
Cancers
Volume 9, Issue 12, Pages 7
Publisher
MDPI AG
Online
2017-01-11
DOI
10.3390/cancers9010007
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lacrimal gland ductal carcinomas: Clinical, Morphological and Genetic characterization and implications for targeted treatment
- (2016) Simon Andreasen et al. ACTA OPHTHALMOLOGICA
- PTEN loss as a predictive biomarker for the Akt inhibitor ipatasertib combined with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC)
- (2016) J.S. de Bono et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Tumor Inhibition by Enzalutamide in a Xenograft Model of Ovarian Cancer
- (2016) Brian Y. Park et al. CANCER INVESTIGATION
- Androgen receptor signaling pathways as a target for breast cancer treatment
- (2016) Elisabetta Pietri et al. ENDOCRINE-RELATED CANCER
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- A Protective Role for Androgen Receptor in Clear Cell Renal Cell Carcinoma Based on Mining TCGA Data
- (2016) Hongjuan Zhao et al. PLoS One
- Enzalutamide inhibits androgen receptor–positive bladder cancer cell growth
- (2016) Takashi Kawahara et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The role of the androgen receptor in ovarian cancer carcinogenesis and its clinical implications
- (2016) Haiyan Zhu et al. Oncotarget
- Androgen receptor as potential therapeutic target in metastatic endometrial cancer
- (2016) Ingvild Løberg Tangen et al. Oncotarget
- An Androgen Receptor–positive Carcinoma of the Lacrimal Drainage System Resembling Salivary Duct Carcinoma
- (2016) Siavash Rahimi et al. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY
- Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancer
- (2015) J. O'Shaughnessy et al. ANNALS OF ONCOLOGY
- Integrative Clinical Genomics of Advanced Prostate Cancer
- (2015) Dan Robinson et al. CELL
- Efficacy of Enzalutamide Following Abiraterone Acetate in Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer Patients
- (2015) Arun A. Azad et al. EUROPEAN UROLOGY
- Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis
- (2015) Yoonseok Kim et al. Journal of Breast Cancer
- Second-Line Therapy for Endometrial Cancer: The Need for Better Options
- (2015) Gini F. Fleming JOURNAL OF CLINICAL ONCOLOGY
- Persistent androgen receptor addiction in castration-resistant prostate cancer
- (2015) Michael T. Schweizer et al. Journal of Hematology & Oncology
- Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma
- (2015) Yun-Sok Ha et al. JOURNAL OF UROLOGY
- Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
- (2015) Charles J Ryan et al. LANCET ONCOLOGY
- Multiple Molecular Subtypes of Triple-Negative Breast Cancer Critically Rely on Androgen Receptor and Respond to Enzalutamide In Vivo
- (2015) V. N. Barton et al. MOLECULAR CANCER THERAPEUTICS
- Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer
- (2015) Zhenfei Li et al. NATURE
- Targeting the MLL complex in castration-resistant prostate cancer
- (2015) Rohit Malik et al. NATURE MEDICINE
- Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel
- (2015) H H Cheng et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Expression of androgen receptor splice variants in clinical breast cancers
- (2015) Theresa E. Hickey et al. Oncotarget
- Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy
- (2014) Woonyoung Choi et al. CANCER CELL
- Flutamide and Biomarkers in Women at High Risk for Ovarian Cancer: Preclinical and Clinical Evidence
- (2014) C. Gruessner et al. Cancer Prevention Research
- ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor-Dependent HIF2 /VEGF Signaling Pathway
- (2014) D. He et al. CANCER RESEARCH
- Rapid Induction of Androgen Receptor Splice Variants by Androgen Deprivation in Prostate Cancer
- (2014) Z. Yu et al. CLINICAL CANCER RESEARCH
- Androgen receptor phosphorylation: biological context and functional consequences
- (2014) Yulia Koryakina et al. ENDOCRINE-RELATED CANCER
- Minireview: SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression
- (2014) Eunpi Cho et al. ENDOCRINOLOGY
- Androgen receptor immunohistochemistry in genitourinary neoplasms
- (2014) Elizabeth M. Williams et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Revising the role of the androgen receptor in breast cancer
- (2014) F M Fioretti et al. JOURNAL OF MOLECULAR ENDOCRINOLOGY
- Therapeutic targeting of BET bromodomain proteins in castration-resistant prostate cancer
- (2014) Irfan A. Asangani et al. NATURE
- AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
- (2014) Emmanuel S. Antonarakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
- (2014) Tomasz M. Beer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical activity of enzalutamide versus docetaxel in men with castration-resistant prostate cancer progressing after abiraterone
- (2014) Daniel L. Suzman et al. PROSTATE
- Tumor clone dynamics in lethal prostate cancer
- (2014) S. Carreira et al. Science Translational Medicine
- Prognostic Value of Sex-Hormone Receptor Expression in Non-Muscle-Invasive Bladder Cancer
- (2014) Jong Kil Nam et al. YONSEI MEDICAL JOURNAL
- Decreased Tumorigenesis and Mortality from Bladder Cancer in Mice Lacking Urothelial Androgen Receptor
- (2013) Jong-Wei Hsu et al. AMERICAN JOURNAL OF PATHOLOGY
- Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100)
- (2013) Y. Loriot et al. ANNALS OF ONCOLOGY
- Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
- (2013) K. L. Noonan et al. ANNALS OF ONCOLOGY
- Clinical activity and tolerability of enzalutamide (MDV3100) in patients with metastatic, castration-resistant prostate cancer who progress after docetaxel and abiraterone treatment
- (2013) Sushil Badrising et al. CANCER
- A Gain-of-Function Mutation in DHT Synthesis in Castration-Resistant Prostate Cancer
- (2013) Kai-Hsiung Chang et al. CELL
- Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
- (2013) A. Gucalp et al. CLINICAL CANCER RESEARCH
- Androgen activates β-catenin signaling in bladder cancer cells
- (2013) Yi Li et al. ENDOCRINE-RELATED CANCER
- Antitumour activity of enzalutamide (MDV3100) in patients with metastatic castration-resistant prostate cancer (CRPC) pre-treated with docetaxel and abiraterone
- (2013) D. Bianchini et al. EUROPEAN JOURNAL OF CANCER
- Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone
- (2013) Andres Jan Schrader et al. EUROPEAN UROLOGY
- Definitive treatment of androgen receptor-positive salivary duct carcinoma with androgen deprivation therapy and external beam radiotherapy
- (2013) Margaret S. Soper et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
- (2013) F. E. Vera-Badillo et al. JNCI-Journal of the National Cancer Institute
- Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer
- (2013) Aye Aye Thike et al. MODERN PATHOLOGY
- Acetylation status of P53 and the expression of DBC1, SIRT1, and androgen receptor are associated with survival in clear cell renal cell carcinoma patients
- (2013) Sang Jae Noh et al. PATHOLOGY
- The Impact of Androgen Receptor Expression on Breast Cancer Survival: A Retrospective Study and Meta-Analysis
- (2013) Qing Qu et al. PLoS One
- Metastatic castration-resistant prostate cancer reveals intrapatient similarity and interpatient heterogeneity of therapeutic kinase targets
- (2013) J. M. Drake et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Serum testosterone levels after medical or surgical androgen deprivation: A comprehensive review of the literature
- (2013) Tsutomu Nishiyama UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- The Expression and Evaluation of Androgen Receptor in Human Renal Cell Carcinoma
- (2013) Guodong Zhu et al. UROLOGY
- Expression of androgen receptors in triple negative breast carcinomas
- (2012) Ivana Mrklić et al. ACTA HISTOCHEMICA
- Immune Cells Have Sex and So Should Journal Articles
- (2012) Sabra L. Klein ENDOCRINOLOGY
- Hepatic androgen receptor suppresses hepatocellular carcinoma metastasis through modulation of cell migration and anoikis
- (2012) Wen-Lung Ma et al. HEPATOLOGY
- Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes*
- (2012) Silvana Di Palma et al. HISTOPATHOLOGY
- Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007
- (2012) Rekha Chandran et al. LEUKEMIA & LYMPHOMA
- Activation of androgen receptor induces ID1 and promotes hepatocellular carcinoma cell migration and invasion
- (2012) Junping Ao et al. Molecular Oncology
- The translational landscape of mTOR signalling steers cancer initiation and metastasis
- (2012) Andrew C. Hsieh et al. NATURE
- Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy
- (2012) Howard I. Scher et al. NEW ENGLAND JOURNAL OF MEDICINE
- Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
- (2012) Charles J. Ryan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of Circulating Cholesterol Levels on Growth and Intratumoral Androgen Concentration of Prostate Tumors
- (2012) Elahe A. Mostaghel et al. PLoS One
- Androgen receptor expression is significantly associated with better outcomes in estrogen receptor-positive breast cancers
- (2011) S. Park et al. ANNALS OF ONCOLOGY
- Targeting Androgen Receptor in Estrogen Receptor-Negative Breast Cancer
- (2011) Min Ni et al. CANCER CELL
- Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes
- (2011) J. L. Wright et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Activation of the Androgen Receptor by Intratumoral Bioconversion of Androstanediol to Dihydrotestosterone in Prostate Cancer
- (2011) James L. Mohler et al. CANCER RESEARCH
- Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants
- (2011) Elahe A. Mostaghel et al. CLINICAL CANCER RESEARCH
- Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1
- (2011) Jessica L L Robinson et al. EMBO JOURNAL
- Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors
- (2011) Muriel Le Romancer et al. ENDOCRINE REVIEWS
- Dihydrotestosterone upregulates the expression of epidermal growth factor receptor and ERBB2 in androgen receptor-positive bladder cancer cells
- (2011) Y. Zheng et al. ENDOCRINE-RELATED CANCER
- Androgen receptor expression is a biological marker for androgen sensitivity in high grade serous epithelial ovarian cancer
- (2011) Ahmed Elattar et al. GYNECOLOGIC ONCOLOGY
- Higher serum testosterone is associated with increased risk of advanced hepatitis C-related liver disease in males
- (2011) Donna L. White et al. HEPATOLOGY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options
- (2011) Heidy C.J. Jaspers et al. JOURNAL OF CLINICAL ONCOLOGY
- SLCO2B1 and SLCO1B3 May Determine Time to Progression for Patients Receiving Androgen Deprivation Therapy for Prostate Cancer
- (2011) Ming Yang et al. JOURNAL OF CLINICAL ONCOLOGY
- Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
- (2011) Laura C Collins et al. MODERN PATHOLOGY
- Abiraterone and Increased Survival in Metastatic Prostate Cancer
- (2011) Johann S. de Bono et al. NEW ENGLAND JOURNAL OF MEDICINE
- Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi-institutional study
- (2010) Carmen Mir et al. BJU INTERNATIONAL
- 3β-Hydroxysteroid Dehydrogenase Is a Possible Pharmacological Target in the Treatment of Castration-Resistant Prostate Cancer
- (2010) Kristen Evaul et al. ENDOCRINOLOGY
- Androgen Receptor Is a Potential Therapeutic Target for Bladder Cancer
- (2010) Ji-Tao Wu et al. UROLOGY
- Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
- (2009) A M Traish et al. BRITISH JOURNAL OF CANCER
- Androgen Receptor Inhibits Estrogen Receptor- Activity and Is Prognostic in Breast Cancer
- (2009) A. A. Peters et al. CANCER RESEARCH
- Sex and racial differences in bladder cancer presentation and mortality in the US
- (2008) Emil Scosyrev et al. CANCER
- Maintenance of Intratumoral Androgens in Metastatic Prostate Cancer: A Mechanism for Castration-Resistant Tumor Growth
- (2008) R. B. Montgomery et al. CANCER RESEARCH
- Androgen Receptor Is a New Potential Therapeutic Target for the Treatment of Hepatocellular Carcinoma
- (2008) Weng–Lung Ma et al. GASTROENTEROLOGY
- Design and End Points of Clinical Trials for Patients With Progressive Prostate Cancer and Castrate Levels of Testosterone: Recommendations of the Prostate Cancer Clinical Trials Working Group
- (2008) Howard I. Scher et al. JOURNAL OF CLINICAL ONCOLOGY
- Hepatitis C Virus Core Protein Augments Androgen Receptor-Mediated Signaling
- (2008) T. Kanda et al. JOURNAL OF VIROLOGY
- Role of sex steroid receptors in pathobiology of hepatocellular carcinoma
- (2008) Mamta Kalra et al. WORLD JOURNAL OF GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started